| Dr Michael Vaughn Baxter Bledsoe, DO | |
|
1320 Maplewood Ave, Ronceverte, WV 24970-8016 | |
| (304) 647-4411 | |
| Not Available |
| Full Name | Dr Michael Vaughn Baxter Bledsoe |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 1320 Maplewood Ave, Ronceverte, West Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770979874 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 3097 (West Virginia) | Primary |
| Entity Name | Boone Memorial Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285686725 PECOS PAC ID: 3375433352 Enrollment ID: O20051111000050 |
News Archive
In a Perspective piece published this week in PNAS, cancer researchers from across the country, including faculty at University of California San Diego School of Medicine and Moores Cancer Center, write that a greater emphasis on immune-based prevention should be central to new efforts like the federal Cancer Moonshot program, headed by Vice President Joe Biden.
Ethicon, Inc., a Johnson & Johnson company and a worldwide leader in surgical care, and Acclarent, Inc., a privately held medical technology company dedicated to designing, developing and commercializing devices that address conditions affecting the ear, nose and throat (ENT), today announced a definitive merger agreement whereby Ethicon will acquire Acclarent in an all-cash transaction for approximately $785 million net of estimated cash on hand at time of closing.
Researchers from the Georgia Institute of Technology and the Centers for Disease Control and Prevention (CDC) have developed a new laboratory test that can rapidly identify the bacterium responsible for staph infections. This new test takes advantage of unique isotopic labeling combined with specific bacteriophage amplification to rapidly identify Staphylococcus aureus.
Scientists at the University of Southern California have applied a nanoscale imaging method to a biological system, helping to clear up an old puzzle of the global carbon and nitrogen cycle.
› Verified 4 days ago
| Entity Name | Boone Memorial Hospital Inc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1639135221 PECOS PAC ID: 3375433352 Enrollment ID: O20061104000273 |
News Archive
In a Perspective piece published this week in PNAS, cancer researchers from across the country, including faculty at University of California San Diego School of Medicine and Moores Cancer Center, write that a greater emphasis on immune-based prevention should be central to new efforts like the federal Cancer Moonshot program, headed by Vice President Joe Biden.
Ethicon, Inc., a Johnson & Johnson company and a worldwide leader in surgical care, and Acclarent, Inc., a privately held medical technology company dedicated to designing, developing and commercializing devices that address conditions affecting the ear, nose and throat (ENT), today announced a definitive merger agreement whereby Ethicon will acquire Acclarent in an all-cash transaction for approximately $785 million net of estimated cash on hand at time of closing.
Researchers from the Georgia Institute of Technology and the Centers for Disease Control and Prevention (CDC) have developed a new laboratory test that can rapidly identify the bacterium responsible for staph infections. This new test takes advantage of unique isotopic labeling combined with specific bacteriophage amplification to rapidly identify Staphylococcus aureus.
Scientists at the University of Southern California have applied a nanoscale imaging method to a biological system, helping to clear up an old puzzle of the global carbon and nitrogen cycle.
› Verified 4 days ago
| Entity Name | Boone Memorial Hospital Inc |
|---|---|
| Entity Type | Part A Provider - Rural Health Clinic |
| Entity Identifiers | NPI Number: 1801039565 PECOS PAC ID: 3375433352 Enrollment ID: O20090421000101 |
News Archive
In a Perspective piece published this week in PNAS, cancer researchers from across the country, including faculty at University of California San Diego School of Medicine and Moores Cancer Center, write that a greater emphasis on immune-based prevention should be central to new efforts like the federal Cancer Moonshot program, headed by Vice President Joe Biden.
Ethicon, Inc., a Johnson & Johnson company and a worldwide leader in surgical care, and Acclarent, Inc., a privately held medical technology company dedicated to designing, developing and commercializing devices that address conditions affecting the ear, nose and throat (ENT), today announced a definitive merger agreement whereby Ethicon will acquire Acclarent in an all-cash transaction for approximately $785 million net of estimated cash on hand at time of closing.
Researchers from the Georgia Institute of Technology and the Centers for Disease Control and Prevention (CDC) have developed a new laboratory test that can rapidly identify the bacterium responsible for staph infections. This new test takes advantage of unique isotopic labeling combined with specific bacteriophage amplification to rapidly identify Staphylococcus aureus.
Scientists at the University of Southern California have applied a nanoscale imaging method to a biological system, helping to clear up an old puzzle of the global carbon and nitrogen cycle.
› Verified 4 days ago
| Entity Name | Camc Greenbrier Valley Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588373872 PECOS PAC ID: 1254702962 Enrollment ID: O20230118000113 |
News Archive
In a Perspective piece published this week in PNAS, cancer researchers from across the country, including faculty at University of California San Diego School of Medicine and Moores Cancer Center, write that a greater emphasis on immune-based prevention should be central to new efforts like the federal Cancer Moonshot program, headed by Vice President Joe Biden.
Ethicon, Inc., a Johnson & Johnson company and a worldwide leader in surgical care, and Acclarent, Inc., a privately held medical technology company dedicated to designing, developing and commercializing devices that address conditions affecting the ear, nose and throat (ENT), today announced a definitive merger agreement whereby Ethicon will acquire Acclarent in an all-cash transaction for approximately $785 million net of estimated cash on hand at time of closing.
Researchers from the Georgia Institute of Technology and the Centers for Disease Control and Prevention (CDC) have developed a new laboratory test that can rapidly identify the bacterium responsible for staph infections. This new test takes advantage of unique isotopic labeling combined with specific bacteriophage amplification to rapidly identify Staphylococcus aureus.
Scientists at the University of Southern California have applied a nanoscale imaging method to a biological system, helping to clear up an old puzzle of the global carbon and nitrogen cycle.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Vaughn Baxter Bledsoe, DO 1320 Maplewood Ave, Ronceverte, WV 24970-8016 Ph: (304) 647-4411 | Dr Michael Vaughn Baxter Bledsoe, DO 1320 Maplewood Ave, Ronceverte, WV 24970-8016 Ph: (304) 647-4411 |
News Archive
In a Perspective piece published this week in PNAS, cancer researchers from across the country, including faculty at University of California San Diego School of Medicine and Moores Cancer Center, write that a greater emphasis on immune-based prevention should be central to new efforts like the federal Cancer Moonshot program, headed by Vice President Joe Biden.
Ethicon, Inc., a Johnson & Johnson company and a worldwide leader in surgical care, and Acclarent, Inc., a privately held medical technology company dedicated to designing, developing and commercializing devices that address conditions affecting the ear, nose and throat (ENT), today announced a definitive merger agreement whereby Ethicon will acquire Acclarent in an all-cash transaction for approximately $785 million net of estimated cash on hand at time of closing.
Researchers from the Georgia Institute of Technology and the Centers for Disease Control and Prevention (CDC) have developed a new laboratory test that can rapidly identify the bacterium responsible for staph infections. This new test takes advantage of unique isotopic labeling combined with specific bacteriophage amplification to rapidly identify Staphylococcus aureus.
Scientists at the University of Southern California have applied a nanoscale imaging method to a biological system, helping to clear up an old puzzle of the global carbon and nitrogen cycle.
› Verified 4 days ago
Dr. Constance L. Anderson, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1320 Maplewood Ave Ste A, Ronceverte, WV 24970 Phone: 304-647-5114 | |
Dr. Debra R Crites-sams, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1478 Maplewood Ave, Ronceverte, WV 24970 Phone: 304-645-4406 Fax: 304-645-4492 | |
Carolyn Bridgett Morrison, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1320 Maplewood Ave, Ronceverte, WV 24970 Phone: 304-645-1787 | |
Dr. Jessica Sue Aliff, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 202 Maplewood Ave, Ronceverte, WV 24970 Phone: 304-647-6529 | |
Leslie Abigail Winters, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 202 Maplewood Ave, Ronceverte, WV 24970 Phone: 304-793-2274 Fax: 304-793-2275 | |
Mrs. Jamie Louise Vance, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1322 Maplewood Ave, Ronceverte, WV 24970 Phone: 304-647-1139 Fax: 304-647-3006 | |
Joshua Paul Ennis, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1320 Maplewood Ave, Ronceverte, WV 24970 Phone: 304-647-4411 |